Screening/testing for pathogen (MRSA, C. diff, etc.) Articles

COVID-19 | 5.20.20

CoachCare HIPAA-compliant Virtual Tools for Clinics During COVID-19

CoachCare’s comprehensive, HIPAA-compliant suite of virtual tools will help you stay connected to patients while practicing social distancing...

COVID-19 | 4.13.20

COVID-19: Preventable Secondary Bacterial Infections/Unnecessary Exposure to Staff

COVID-19 patients, already compromised and fighting for their lives, are subject to copious amounts of pathogen-ridden sputum, making them prime...

Environmental Infection | 9.12.19

Bacteria attributed to sterile gel in ultrasound guided central line insertions

This study describes an outbreak of Burkholderia cenocepacia bacteremia in 4 hospitals across Australia between the dates of March 2017...

Environmental Infection | 9.12.19

Confident Compliance for TEE Ultrasound Probes

Transesophageal (TEE) ultrasound probes are expensive, delicate devices that require a certain level of care. Keep your facility’s TEE probes...

HAIs: Types and Pathogens | 6.18.19

Clostridioides difficile (formally Clostridium difficile) infection educational booklet

Clostridioides difficile (formally Clostridium difficile, or C. diff) infection (CDI) is considered a worldwide threat with major consequences for morbidity,...

Diagnostics | 1.9.19

Benefits of Presurgical MRSA Testing

With our aging population in the US, the projection for the number of total hip and total knee arthroplasty procedures...

HAIs: Types and Pathogens | 8.23.18

Infographic: Impact of MRSA/S. aureus Colonization on SSIs

Reduce Joint Replacement Surgical Site Infections (SSIs) with Molecular Testing

Colonized patients are up to 9 times more likely to develop...

Diagnostics | 7.12.18

Presurgical Molecular Testing for Staphylococcal Nasal Colonization

Routine molecular testing of the nares for the presence of Staphylococcus aureus followed by targeted decolonization of patients carrying either...